Hospira Gemcitabine for IV Infusion 1 g

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

gemcitabine hydrochloride, Quantity: 45.54 mg/mL

Dostępny od:

Hospira Australia Pty Ltd

INN (International Nazwa):

Gemcitabine hydrochloride

Forma farmaceutyczna:

Injection, intravenous infusion

Skład:

Excipient Ingredients: mannitol; sodium acetate trihydrate

Droga podania:

Intravenous Infusion

Sztuk w opakowaniu:

1 x 50 mL vial

Klasa:

Medicine Listed (Export Only)

Typ recepty:

(S1) This Schedule is intentionally blank

Wskazania:

Non-small cell lung cancer, pancreatic cancer, biliary tract cancer, uroepithelial cancer, inoperable or recurrent breast cancer, ovarian cancer progressing after chemotherapy.

Podsumowanie produktu:

Visual Identification: A white to off white lyophilized powder in a clear glass vial; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autoryzacji:

Listed (Export Only)

Data autoryzacji:

2013-01-07